Avian hepatitis E vaccine and diagnostic kit for poultry
This technology provides the foundation for preventing and diagnosing Hepatitis E Virus (HEV) infections in poultry and potentially mammals. Researchers have isolated a specific avian strain of the virus and identified its genetic markers, enabling the production of vaccines using weakened viruses or specific proteins. The invention also covers diagnostic tools, such as PCR primers and antibody tests, to detect the presence of the virus in flocks. By targetting the 'ORF2' protein, the vaccine triggers an immune response without causing the disease itself.
What you could build
A commercial poultry vaccine and companion diagnostic kit sold to large-scale chicken producers and hatcheries to manage flock health and prevent HEV outbreaks.
Who in Virginia should care
Virginia's significant poultry industry, particularly in the Shenandoah Valley, would benefit from improved viral management tools to protect livestock yields.
Readiness: Prototype likely
Concept — described but not yet demonstrated. Lab validated — supported by experimental results in the patent. Prototype likely — the text describes a built, working embodiment.
Readiness is inferred from the patent text, not from a lab visit.
The record
- Inventors
- Xiang-Jin Meng, Gholamreza Haqshenas, Fang-Fang Huang
- Granted
- November 30, 2010
- Status
- Granted patent
- Patent number
- 7842298
Ready to talk?
Virginia Tech Intellectual Properties handles licensing for this technology.
Prosim summaries are generated from public patent text and are not legal advice.